title: Management of recurrent miscarriage.
abstract: Recurrent miscarriage is classically defined as three or more consecutive pregnancy losses. Many researchers have now revised this definition to two or more pregnancy losses because of the recent increase in the prevalence of childless couples. Established causes of recurrent miscarriage are antiphospholipid antibodies, uterine anomalies and abnormal chromosomes in either partner, particularly translocations. Antiphospholipid syndrome is the most important treatable cause of recurrent miscarriage. However, it is not yet established as to what kind of testing should be conducted in patients with recurrent pregnancy loss. Standardization of tests for antiphospholipid antibodies is needed. On the other hand, embryonic aneuploidy is the most frequent cause of recurrent miscarriage. Chromosome analysis of the embryo is important, because it has good predictive value for subsequent live birth. It is not necessary to give any medications for unexplained cases of recurrent miscarriage, and provision of psychological support may be the most important to encourage the couples to continue to conceive until a live birth results.
authors.affiliation: Department of Obstetrics and Gynecology, Graduate School of Medical Sciences, Nagoya City University, Nagoya, Japan.
authors.forename: Mayumi
authors.initials: M
authors.lastname: Sugiura-Ogasawara
authors.forename: Yasuhiko
authors.initials: Y
authors.lastname: Ozaki
authors.forename: Nobuhiro
authors.initials: N
authors.lastname: Suzumori
mesh_terms: D059786:Abnormal Karyotype; D000026:Abortion, Habitual / Q000209:etiology / Q000628:therapy*; D000328:Adult; D016736:Antiphospholipid Syndrome / Q000150:complications; D002869:Chromosome Aberrations; D005260:Female; D006801:Humans; D011247:Pregnancy; D014599:Uterus / Q000002:abnormalities
keywords: antiphospholipid antibodies; embryonic karyotype; recurrent miscarriage; translocation; uterine anomalies